Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) Treatment in Patients With Rheumatoid Arthritis
This update reports the completion of a non-interventional observational study evaluating tocilizumab (RoActemra/Actemra) in patients with r…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs
An observational study of tocilizumab (RoActemra/Actemra) in rheumatoid arthritis patients who had an inadequate response to DMARDs has comp…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor. [Phase 4]
A Phase 4 trial evaluating MabThera (rituximab) in rheumatoid arthritis patients who had an inadequate response to a single anti-TNF inhibit…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Early Moderate to Severe Rheumatoid Arthritis Who Completed Study WA19926 [Phase 3]
This entry covers a long-term extension study of tocilizumab (RoActemra/Actemra) in patients with early moderate to severe rheumatoid arthri…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO)
This update reports that the non-interventional MONACO study evaluating tocilizumab as monotherapy in rheumatoid arthritis has been terminat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: An Observational Study of RoActemra/Actemra (Tocilizumab) in Rheumatoid Arthritis Patients
This document reports an observational study of tocilizumab (RoActemra/Actemra) used in patients with rheumatoid arthritis. The study has co…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug. [Phase 4]
This document reports that the Phase 4 SWITCH trial in rheumatoid arthritis patients who failed an initial TNF-blocking therapy has complete…
-
CLINICAL_TRIALS research · 2016-11-02Clinical Trial Update: An Observational Study of Dosage Patterns in Routine Clinical Practice in Patients With Rheumatoid Arthritis (ACT-LIFE)
An observational study (ACT-LIFE) evaluating real-world dosage patterns in rheumatoid arthritis patients is completed, sponsored by Hoffmann…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study Assessing the Safety and Efficacy of Subcutaneous RoActemra/Actemra Alone or in Combination With Non-biologic Antirheumatics in Rhuematoid Arthritis Patients in Latin America With Inadequate Response to Non-biologic Antirheumatic Drugs. [Phase 3]
Phase 3 study evaluating subcutaneous RoActemra/Actemra as monotherapy or with non-biologic DMARDs in rheumatoid arthritis patients in Latin…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis [Phase 2]
Phase 2 study of a P38 inhibitor as monotherapy in active rheumatoid arthritis has completed.
-
CLINICAL_TRIALS withdrawal · 2016-11-02Clinical Trial Update: A Non-Interventional Study in Patients With Rheumatoid Arthritis Who Are Treated With RoActemra/Actemra (Tocilizumab)
A non-interventional study of rheumatoid arthritis patients treated with RoActemra/Actemra (tocilizumab) has been withdrawn.
-
CLINICAL_TRIALS research · 2016-11-02Clinical Trial Update: A Retrospective Chart Review of MabThera (Rituximab) Treatment in Rheumatoid Arthritis (RA) Participants in Australia
This is a completed retrospective chart review assessing the use of MabThera (rituximab) in Australian patients with rheumatoid arthritis.
-
CLINICAL_TRIALS research · 2016-11-02Clinical Trial Update: An Observational Study of Rituximab in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis
An observational study evaluating the combination of rituximab and methotrexate in participants with active rheumatoid arthritis; the study …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy [Phase 2]
A Phase 2 study of a P38 MAP kinase inhibitor (code 4) in rheumatoid arthritis patients on stable methotrexate has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Mabthera Alone and in Combination With Either Cyclophosphamide or Methotrexate in Patients With Rheumatoid Arthritis [Phase 2]
A Phase 2 clinical trial evaluated the efficacy and safety of Mabthera (rituximab) alone and in combination with cyclophosphamide or methotr…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)
This clinical trial evaluated golimumab (Simponi) in adults with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. The …
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Safety and Efficacy Vagal Nerve Stimulation in Patients With Rheumatoid Arthritis [NA]
Completed clinical trial evaluating the safety and efficacy of vagal nerve stimulation in patients with rheumatoid arthritis. The trial is s…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis [Phase 4]
Phase 4 trial in early rheumatoid arthritis evaluated starting adalimumab after methotrexate failure. The study results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Long Term Extension Study For SPM-005 Participants [Phase 1, Phase 2]
A long-term extension study update for SPM-005 in rheumatoid arthritis, covering Phase 1 and Phase 2 participants.
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid Arthritis [Phase 2]
A Phase 2 study evaluating mavrilimumab versus anti-TNF therapy in rheumatoid arthritis completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Mid-term Outcomes of First MTP Arthroplasty With Primus™ FGT Implant.
This clinical trial update reports mid-term outcomes for the first metatarsophalangeal joint arthroplasty using the Primus FGT implant in pa…
-
CLINICAL_TRIALS withdrawal · 2016-10-31Clinical Trial Update: 99m-Technetium- Glucosamine in Arthritis
A clinical trial evaluating 99m-Technetium-Glucosamine for rheumatoid arthritis and ankylosing spondylitis is no longer available, indicatin…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid Arthritis
This clinical trial update summarizes a prospective observational study of tocilizumab in rheumatoid arthritis, noting the study was complet…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice
This entry reports results from an observational study evaluating tocilizumab as monotherapy for rheumatoid arthritis in routine clinical pr…
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine [Phase 3]
A Phase 3 study evaluating subcutaneous sirukumab (CNTO 136) in Japanese patients with active rheumatoid arthritis unresponsive to methotrex…